Advertisement

Approach to Diagnosis

  • Raghuwansh P. Sah
  • Suresh T. Chari
Chapter

Abstract

Autoimmune pancreatitis (AIP) is a rare disease which is characteristically responsive to steroid treatment. Its clinical presentation mimics that of pancreatic cancer which is far more common than AIP. The price of misdiagnosis is heavy as AIP mistaken for pancreatic cancer leads to major pancreatic surgery. Similarly, pancreatic cancer misdiagnosed as AIP leads to delay in diagnosis and possible progression of cancer while receiving steroid therapy. Recently, international consensus diagnostic criteria have been formulated for the diagnosis of AIP and to distinguish it from pancreatic cancer. These criteria utilize a combination of histology, pancreatic imaging features, evidence of extrapancreatic manifestations, IgG4 serology, and response to steroid treatment. Histological confirmation of AIP is difficult preoperatively; however, noninvasive diagnosis of AIP can be made in about 50 % of patients based on radiological and serological features. In a select group of patients with specific features, a diagnostic steroid trial is appropriate. About 20 % of patients do not have any evidence of extrapancreatic organ involvement or IgG4 serum elevation; in these patients, histological confirmation is required to definitively diagnose AIP.

Keywords

Pancreatic Cancer Autoimmune Pancreatitis Lymphoplasmacytic Infiltrate Storiform Fibrosis Bile Duct Involvement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139(1):140–8. quiz e12-3.PubMedCrossRefGoogle Scholar
  2. 2.
    Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2012. doi: 10.1136/gutjnl-2012-303617.
  3. 3.
    Kamisawa T, Chari ST, Giday SA, et al. Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas. 2011;40(6):809–14.PubMedCrossRefGoogle Scholar
  4. 4.
    Sah RP, Pannala R, Chari ST, et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol. 2010;8(1):91–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Nishimori I, Tamakoshi A, Otsuki M. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol. 2007;42 Suppl 18:6–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Kanno A, Nishimori I, Masamune A, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan. Pancreas. 2012;41(6):835–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.PubMedCrossRefGoogle Scholar
  8. 8.
    Wolfson D, Barkin JS, Chari ST, et al. Management of pancreatic masses. Pancreas. 2005;31(3):203–17.PubMedCrossRefGoogle Scholar
  9. 9.
    Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40(3):352–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4(8):1010–6. quiz 934.PubMedCrossRefGoogle Scholar
  11. 11.
    Okazaki K, Kawa S, Kamisawa T, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol. 2010;45(3):249–65.PubMedCrossRefGoogle Scholar
  12. 12.
    Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43(6):403–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol. 2009;104(9):2288–94.PubMedCrossRefGoogle Scholar
  14. 14.
    Schneider A, Lohr JM, Singer MV. The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol. 2007;42(2):101–19.PubMedCrossRefGoogle Scholar
  15. 15.
    Chari ST, Takahashi N, Levy MJ, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol. 2009;7(10):1097–103.PubMedCrossRefGoogle Scholar
  16. 16.
    Moon SH, Kim MH, Park DH, et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut. 2008;57(12):1704–12.PubMedCrossRefGoogle Scholar
  17. 17.
    Mizuno N, Bhatia V, Hosoda W, et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol. 2009;44(7):742–50.PubMedCrossRefGoogle Scholar
  18. 18.
    Iwashita T, Yasuda I, Doi S, et al. Use of samples from endoscopic ultrasound-guided 19-gauge fine-needle aspiration in diagnosis of autoimmune pancreatitis. Clin Gastroenterol Hepatol. 2012;10(3):316–22.PubMedCrossRefGoogle Scholar
  19. 19.
    Sugumar A, Levy MJ, Kamisawa T, et al. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut. 2011;60(5):666–70.PubMedCrossRefGoogle Scholar
  20. 20.
    Moon SH, Kim MH, do Park H, et al. IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis. Gastrointest Endosc. 2010;71(6):960–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Kamisawa T, Tu Y, Egawa N, et al. A new diagnostic endoscopic tool for autoimmune pancreatitis. Gastrointest Endosc. 2008;68(2):358–61.PubMedCrossRefGoogle Scholar
  22. 22.
    Rebours V, Le Baleur Y, Cazals-Hatem D, et al. IgG4 immunostaining of gastric, duodenal or colonic biopsies is not helpful for the diagnosis of autoimmune pancreatitis. Clin Gastroenterol Hepatol. 2012;10(1):91–4.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Internal Medicine, Mayo Clinic RochesterRochesterUSA
  2. 2.Division of Gastroenterology and Hepatology, Internal MedicineMayo Clinic College of MedicineRochesterUSA

Personalised recommendations